INBRAIN Neuroelectronics was established in 2019 and uses technology developed by Graphene Flagship partners ICN2, ICREA and the University of Manchester to develop smart devices for patients with neurological disorders, such as Parkinson’s or epilepsy.

With the project’s first product, INBRAIN has enabled effective real-time brain mapping and minimally invasive brain resection applications with their graphene-based brain implants.

Watch the video below to gain insight into how INBRAIN strive to decode brain signals into medical solutions that will actively alleviate the strain on neurological disorders that 165 million Europeans are currently living with.